[
  {
    "ts": null,
    "headline": "Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced",
    "summary": "Zimmer Biomet Holdings, Inc. reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$2,243.8 million from US$2,023.2 million a year earlier, while quarterly net income fell to US$139.3 million from US$239.4 million. Alongside the earnings release, Zimmer Biomet completed a prior US$1,229.78 million buyback and authorized a new US$1,500 million repurchase program, signaling continued emphasis on returning capital to shareholders despite lower earnings. We’ll now...",
    "url": "https://finnhub.io/api/news?id=da7b288b56fd9112605012d37a790aaeabd4a80def2e7e8dfae6e1f2ae1e0731",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770830097,
      "headline": "Zimmer Biomet (ZBH) Is Up 6.1% After Earnings Beat And New Buyback Plan Is Announced",
      "id": 139046744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$2,243.8 million from US$2,023.2 million a year earlier, while quarterly net income fell to US$139.3 million from US$239.4 million. Alongside the earnings release, Zimmer Biomet completed a prior US$1,229.78 million buyback and authorized a new US$1,500 million repurchase program, signaling continued emphasis on returning capital to shareholders despite lower earnings. We’ll now...",
      "url": "https://finnhub.io/api/news?id=da7b288b56fd9112605012d37a790aaeabd4a80def2e7e8dfae6e1f2ae1e0731"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer plans US salesforce reorganization",
    "summary": "Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.",
    "url": "https://finnhub.io/api/news?id=0b1d7b10b94c4aaf7b761307d69e8da97894f456670e26e039fd4c0f8ea2227e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770810064,
      "headline": "Zimmer plans US salesforce reorganization",
      "id": 139046745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.",
      "url": "https://finnhub.io/api/news?id=0b1d7b10b94c4aaf7b761307d69e8da97894f456670e26e039fd4c0f8ea2227e"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $98",
    "summary": "Wells Fargo  analyst Larry Biegelsen   maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $93 to $98.",
    "url": "https://finnhub.io/api/news?id=f6c1b98e2a6f51d259349149d6208e760adfab58f31e12aba416e32798cf2f13",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770807570,
      "headline": "Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $98",
      "id": 139058189,
      "image": "",
      "related": "ZBH",
      "source": "Benzinga",
      "summary": "Wells Fargo  analyst Larry Biegelsen   maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $93 to $98.",
      "url": "https://finnhub.io/api/news?id=f6c1b98e2a6f51d259349149d6208e760adfab58f31e12aba416e32798cf2f13"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?",
    "summary": "Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.",
    "url": "https://finnhub.io/api/news?id=06e90d37d1b090337f39546e43e7d2c86fbd6f2433057db83643c0d14a9d3b2e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770800258,
      "headline": "Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?",
      "id": 139041194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.",
      "url": "https://finnhub.io/api/news?id=06e90d37d1b090337f39546e43e7d2c86fbd6f2433057db83643c0d14a9d3b2e"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Q4 Earnings Call Highlights",
    "summary": "Zimmer Biomet (NYSE:ZBH) reported fourth-quarter 2025 results that management said met its commitments on sales growth, earnings, and free cash flow despite tariff headwinds and the integration of three acquisitions during the year. Executives also outlined a major ongoing shift in the company’s U.S",
    "url": "https://finnhub.io/api/news?id=72e3dfd6d00b4188718163e553dec792ffb3d100b13e8b44f2282788ddde3a49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770793633,
      "headline": "Zimmer Biomet Q4 Earnings Call Highlights",
      "id": 139039955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet (NYSE:ZBH) reported fourth-quarter 2025 results that management said met its commitments on sales growth, earnings, and free cash flow despite tariff headwinds and the integration of three acquisitions during the year. Executives also outlined a major ongoing shift in the company’s U.S",
      "url": "https://finnhub.io/api/news?id=72e3dfd6d00b4188718163e553dec792ffb3d100b13e8b44f2282788ddde3a49"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum",
    "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per share was 0.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=8b9df55750fab84cb7b22aa2edda4d1e3bc798ee0920b7789a1673c366ccf8ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770787879,
      "headline": "ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum",
      "id": 139042741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.9% year on year to $2.24 billion. Its non-GAAP profit of $2.42 per share was 0.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=8b9df55750fab84cb7b22aa2edda4d1e3bc798ee0920b7789a1673c366ccf8ed"
    }
  }
]